Compare companies

Pick 2–4 companies for a side-by-side spec sheet.

Selected: 1 / 4

Side by side

FieldChai Discovery
Categories
foundation-modelshealthcare
HQSan Francisco, California, USA
Founded2024
Latest valuation$1.3B
Annual Recurring Revenue (ARR)—
Funding to date$225M+
Headcount—
Profitability—
Statusactive
Pricing tierenterprise
DescriptionAI-native biotech company that predicts and reprograms interactions between biochemical molecules for drug discovery. Builds foundation models tuned to design novel antibodies and therapeutic molecules with improved developability properties, tackling historically hard-to-drug targets.